36 results about "Medicinal mushroom" patented technology

The present invention utilizes fungal spore mass or hyphal fragments in burlap bags or sacks filled with biodegradable materials. The fungi may include saprophytic fungi, including gourmet and medicinal mushrooms, mycorrhizal fungi, entomopathogenic fungi, parasitic fungi and fungi imperfecti. The fungi function as keystone species, delivering benefits to both the microsphere and biosphere. Such fungal delivery systems are useful for purposes including ecological rehabilitation and restoration, preservation and improvement of habitats, bioremediation of toxic wastes and polluted sites, filtration of agricultural, mine and urban runoff, improvement of agricultural yields and control of biological organisms.

Compounds having unique antiviral and antibacterial properties are prepared from medicinal mushroom mycelium, extracts and derivatives. The compositions are derived from Fomitopsis, Piptoporus, Ganoderma, Inonotus, Trametes, Pleurotus, and blends of medicinal mushroom species and are useful in preventing and treating viruses including Poxyiridae and Orthopox viruses, flu viruses including bird flu (H5N1), SARS and Hepatitis C(HCV), as well as infections from Mycobacterium tuberculosis, Staphylococcus aureus and Escherichia coli.

Compounds having unique antiviral properties found in mushroom mycelium and their analogs are extracted, concentrated, isolated or manufactured to create compositions useful in preventing the spread and proliferation of various viruses afflicting animals, particularly viruses harming humans, pigs, birds, bats and bees. Such compounds and compositions can be used individually or in combination with known medicines or natural products to improve health.

The present invention utilizes fungal spore mass or hyphal fragments in landscaping cloths, fiber substrates, paper products, hydroseeders and agricultural equipment. The fungi may include saprophytic fungi, including gourmet and medicinal mushrooms, mycorrhizal fungi, entomopathogenic fungi, parasitic fungi and fungi imperfecti. The fungi function as keystone species, delivering benefits to both the microsphere and biosphere. Such fungal delivery systems are useful for purposes including ecological rehabilitation and restoration, preservation and improvement of habitats, bioremediation of toxic wastes and polluted sites, filtration of agricultural, mine and urban runoff, improvement of agricultural yields and control of biological organisms. The invention allow for a variety of methods and products including the use of cardboard boxes as a delivery system for fungi with or without the combination with plant seeds for starting gardens, for controlling insects, or for the process of ecological recovery.

Compounds having unique antiviral properties are prepared from medicinal mushroom mycelium, extracts and derivatives. The compositions are derived from Fomitopsis and blends of medicinal mushroom species and are useful in preventing and treating viruses including Poxviridae and Orthopox viruses.

The present invention deals with the production of food products with a health promoting effect, namely immune modulation in general, and lowering and / or stabilizing blood sugar levels. The food products concerned comprise polysaccharides from edible or medicinal mushrooms. These are produced through fermentation instead of conventional cultivation of mushrooms. Fermentation process is preferably done in submerged cultures, especially fed-batch or step-up cultures.

Compounds having unique antiviral properties are prepared from medicinal mushroom mycelium, extracts and derivatives. The compositions are derived from Fomitopsis, Piptoporus, Ganoderma and blends of medicinal mushroom species and are useful in preventing and treating viruses including Orthopox viruses, influenza, avian influenza, Venezuelan Equine Encephalitis, yellow fever, West Nile, Dengue, New World and Old World arenaviruses, hantavirus, Rift Valley fever, sandfly fever, hantavirus, SARS, Rhinovirus and other viruses.

Compounds having unique antiviral properties are prepared from medicinal mushroom mycelium, extracts and derivatives. The compositions are derived from Fomitopsis, Piptoporus, Ganoderma resinaceum and blends of medicinal mushroom species and are useful in preventing and treating viruses including Pox and HIV viruses.

The invention relates to an edible mushroom culture medium, a manufacturing method thereof and an edible mushroom culture method and belongs to the field of edible medicinal mushroom production and viewing. The edible mushroom culture medium is characterized by being formed by inoculating a cut log with an edible mushroom strain and winding a plastic film outside the cut log after culture of edible mushroom mycelium is finished. The proper cut log and mushroom strain are selected and proper culture conditions are adopted according to different types of edible mushrooms. After culture of the edible mushroom mycelium in the cut log is finished, the cut log is taken out from a plastic bag, and the plastic film is wound outside the cut log. According to requirements, a hole of 5mm-20mm is shorn on the plastic film at the portion where an edible mushroom entity is planned to grow, and the edible mushroom entity can grow out from the shorn hole. The medium and the methods solve the problem of pesticide residue in edible mushroom culture through the cut log, and the culture process and products of the edible mushroom culture through the cut log are introduced to the field of viewing. By means of the medium and the methods, three-dimensional edible mushroom culture through the cut log is possible, land covering cost is reduced, and clean culture and direct fresh eating of edible mushrooms become possible.

Compounds having unique antiviral and antibacterial properties are prepared from medicinal mushroom mycelium, extracts and derivatives. The compositions are derived from Fomitopsis, Piptoporus, Ganoderma, Inonotus, Trametes, Pleurotus, and blends of medicinal mushroom species and are useful in preventing and treating viruses including Poxyiridae and Orthopox viruses, flu viruses including bird flu (H5N1), SARS and Hepatitis C (HCV), as well as infections from Mycobacterium tuberculosis, Staphylococcus aureus and Escherichia coli.

The present invention relates to a process for producing flavone through liquid-solid double-phase culture of medicinal mushroom phellinus igniarius, and belongs to the technical field of biological fermentation engineering. According to the present invention, mainly during a phellinus igniarius liquid fermentation process, a macroporous absorption resin is added to a culture liquid to establish a liquid-solid double-phase culture system so as to improve a flavone yield; with the double-phase culture process, the flavone yield can be up to 2174.35 mug / ml and is increased by 35% compared with the control; and the process has characteristics of simple operation and strong generalization, and is especially suitable for large-scale higher fungi fermentation and active substance production.

Compounds having unique antiviral properties found in mushroom mycelium and their analogs are extracted, concentrated, isolated or manufactured to create compositions useful in preventing the spread and proliferation of various viruses afflicting animals, particularly viruses harming humans, pigs, birds, bats and bees. Such compounds and compositions can be used individually or in combination with known medicines or natural products to improve health.

A composition useful for treating immune-mediated inflammatory diseases or cancer in mammalian subjects is disclosed. The composition comprises a synergistic combination of a cannabis derived compound, and a medicinal mushroom.

The invention relates to novel rare edible mushrooms and culture technologies thereof, in particular to a novel piptoporus solonjensis strain, a culture method based on a mushroom bran matrix and application of the novel piptoporus solonjensis strain. The novel piptoporus solonjensis strain is Piptoporus solonjensis HMGIM-A150751, and a preservation number is CCTCC NO: M 2018756. The invention provides the novel piptoporus solonjensis strain and the corresponding artificial culture method. The novel piptoporus solonjensis strain and the corresponding artificial culture method have the beneficial effects that the culture method is low in cost and high in efficiency; the novel piptoporus solonjensis strain are edible-medicinal mushrooms which are low in fat, high in protein, high in folic acid, high in niacin and rich in potassium and magnesium, the nutrition value is high, effective component contents are high, and the novel piptoporus solonjensis strain can be developed to be used forinhibiting mouse breast cancer cell proliferation, and has excellent economic benefits and social benefits.

The invention discloses a medicinal cushion with Chinese herbal medicines for a bathing towel. The invention has the aim of providing a bathing article with the functions of prevention and health care to skin for overcoming the defect of a background technology. The medicinal cushion with the Chinese herbal medicines for the bathing towel comprises moxa, roses, solanum vines, valerian, rhizoma nardostachyos, fructus kochiae, fructus cnidii, kuh-seng, lindera glauca leaves and the like. The traditional Chinese medicines are prepared into the medicinal cushion, and the medicinal cushion is added with a non-woven fabric and is fixed, sheared, sealed and packaged. When the medicinal cushion with the Chinese herbal medicines for the bathing towel is used, the medicinal cushion is placed into apurpose-made bathing and rubbing towel (a soft face) so as to soak the medicinal cushion, the skin is repeatedly rubbed and washed, and then the residual medicine is completely flushed by using purified water. Or, the medicinal cushion is directly placed into a bathtub for releasing the medicine effect of the medicinal cushion into water, then a whole body is soaked in the medicinal water for 10 minutes, and afterwards the residual medicine is completely flushed by using the purified water. The medicinal cushion with the Chinese herbal medicines for the bathing towel has a favorable improvingfunction to mental and physical fatigue, dreaminess, insomnia, skin dryness, skin pruritus and hair wilt. The medicinal cushion with the Chinese herbal medicines for the bathing towel has the characteristics of low price and convenience in use.

Processes for preparing lanostane triterpenes from the medicinal mushroom Ganoderma lucidum, and related compounds are described. Compounds, compositions, and methods for treating cancer are also described.

The invention discloses vermicelli containing hydrangea, the raw material of which consists of hydrangea, Hericium erinaceus, Coprinus comatus, Russula, Flammulina velutipes, Lentinus edodes, Morchella, Tea tree mushroom, Hazel mushroom, Bailing mushroom, Big bald puffball , Agaricus blazei, bamboo fungus and rice. In the present invention, a variety of edible and medicinal mushrooms such as Hydrangea are used to make a slurry, and then beaten with rice to make vermicelli. , help digestion, whiten and beautify the skin, delay aging, enhance immunity and other health effects.

The invention relates to an edible and medicinal mushroom soup seasoning, which belongs to the field of food technology, and is characterized in that it is made of the following raw materials in the following weight proportions: 80-90 parts of concentrated bone broth, 10-20 parts of salt, 7‑10 parts of animal oil, 20‑35 parts of morel mushrooms, 10‑30 parts of matsutake mushrooms, 10‑30 parts of black tiger palm, 10‑30 parts of tea tree mushrooms, 10‑30 parts of rehmannia, 5 parts of delicious porcini mushrooms 9 servings, 10-30 servings of Lycium barbarum, 10-30 servings of oyster mushroom, 10-30 servings of mushroom, 10-30 servings of Hericium erinaceus, 5-9 servings of Grifola frondosa, 10-30 servings of truffle, 10-serving poria cocos 30 parts, 10‑30 parts of big bald puffball, 1‑5 parts of Polyporus, 1‑5 parts of white fungus. The beneficial effects of the invention are: selection of raw materials, scientific formula, delicious taste, sweet and refreshing, long aftertaste, convenient storage, easy absorption by human body, and effective improvement of human immunity.

The invention discloses an edible and medicinal mushroom food composition and a preparation method thereof. The food composition comprises the following raw materials in parts by weight: 200-600 parts of glossy ganoderma polysaccharide, 300-600 parts of cordyceps sinensis polysaccharide, 1600-2200 parts of agaricus bisporus, 300-600 parts of lentinan, 700-1100 parts of tricholoma quercicola zang and 200-600 parts of funguses. The preparation method comprises the following steps of thoroughly cleaning the agaricus bisporus, the tricholoma quercicola zang and the funguses, performing airing or baking, performing crushing to obtain powder of which the particle diameters are 1-2cm, mixing the powder with the glossy ganoderma polysaccharide, the cordyceps sinensis polysaccharide and the lentinan, and performing superfine crushing to obtain powder of which the particle diameters are 20-200[mu]m so that the food composition is obtained. The food composition disclosed by the invention has the efficacy of softening hard lumps, dispelling nodes, expelling blood stasis and removing toxicity, has the effect of directly killing malignant swelling and aching cells, and particularly has good treatment effects on lobular hyperplasia of the mammary gland, cystic hyperplasia disease of the mammary gland or tumor of the mammary gland. The food composition disclosed by the invention has the characteristics of being good in treatment effects, simple in treatment manner, high in cure rate, low in price and short in cure time, and the immune system and the lactation system of women patients are prevented from being damaged.

The invention relates to preservation of edible mushroom strains, in particular to a simple preserving method of edible and medicinal mushroom strains. The simple preserving method comprises the stepsof (1) inoculating strains to a plate culture medium, uniformly drilling plat strains which are cultured through a bacteria-free hole puncher, preparing strain blocks being 0.4-0.5cm in diameter, anduniformly inoculating the strain blocks to a new plate culture medium; (2) placing filter paper sheets around the strain blocks, and maintaining distances between the filtering sheets; (3) performingplate culturing after inoculating until mycelium completely covers the filter paper sheets; (4) gently uncovering the filter paper sheets covered with the edible and medicinal mushroom mycelium basedon the condition that the culture medium is not stuck, and performing transferring to a bacteria-free kraft paper envelope; and (5) putting the kraft paper envelope loaded with the mycelium filteringpaper sheets in discoloured silica gel performing drying, performing normal-temperature placing in a sealed container for 10-15 days, then sealing the kraft paper envelope, and performing moving to 4DEG C for short-time preservation or express circulation. The method is simple and easy to operate, good in mycelium consistency, used for short-term preservation, and favorable for follow-up study.

A composition for treating opioid withdrawal and method of manufacture and administration of the composition creates a synergistic combination of cannabinoids, terpenoids, herbs, and medicinal mushrooms that help to eliminate the symptoms of opioid withdrawal by creating a medicinal entourage. The composition combines: between about 2.5 to 100 milligrams of a cannabinoid, between about 0.084 to 33.6 milligrams of a terpenoid, between about 0.5 to 3000 milligrams of an herb, and between about 25 to 2500 milligrams of a medicinal mushroom. The composition is orally administered in a lipid-enclosed capsule form. The terpenoid has a lipophilic nature that enhances the bioavailability of the cannabinoid. The herb works with the body's endocannabinoid system to enhance pain relief capacity of the cannabinoid, so as to help inhibit symptoms of opioid withdrawal. The medicinal mushroom comprises a psychedelic drug that creates a therapeutic effect with the cannabinoid to inhibit symptoms of opioid withdrawal.

The invention discloses a method for providing air for the artificial culture of medicinal mushrooms, which adopts a technical proposal of adding ozone for providing air during the artificial culture of the medicinal mushrooms. The inventor has applied for a patent on artificial oxygen-enriched air environment of high commercial value, which is obtained in the environment for industrial artificial culture of cordyceps. A technology adopted in the invention is to add ozone to the culture environment, so as to increase the output of cordyceps products or improve the effective element of the cordyceps through the stimulation of the ozone.

The invention relates to an edible and medicinal fungus soup stock, which belongs to the technical field of food, and is characterized in that it is made of the following raw materials in the weight ratio: 80-90 parts of concentrated bone broth, 10-20 parts of salt, vegetable oil 7‑10 parts, 20‑35 parts morel mushrooms, 10‑30 parts matsutake mushrooms, 10‑30 parts black tiger palm mushrooms, 10‑30 parts tea tree mushrooms, 10‑30 parts rehmannia, 5‑9 delicious porcini mushrooms 10-30 servings of medlar, 10-30 servings of oyster mushroom, 10-30 servings of mushroom, 10-30 servings of Hericium erinaceus, 5-9 servings of old man’s head mushroom, 10-30 servings of truffle, 10-30 serving of dry mushroom 10-30 servings of black sesame, 1-5 servings of Polyporus, and 1-5 servings of white fungus. The beneficial effects of the invention are: selection of raw materials, scientific formula, delicious taste, sweet and refreshing, long aftertaste, convenient storage, easy absorption by human body, and effective improvement of human immunity.

The invention relates to a new variety of Grifola frondosa in facility cultivation and a method for preparing the same by liquid fermentation, and belongs to an edible and medicinal fungus and a method for making the same by liquid fermentation. General Microbiology Center of China Microbiological Culture Collection Management Committee, the preservation number is CGMCC No.14354, and the preservation date is July 19, 2017. The new variety of Grifola frondosa of the present invention is relatively low temperature resistant, the cultivation period is short, and the biological conversion rate can reach 40%. Automated cultivation, suitable for facility cultivation in Northeast and North China. The production technology of this variety of Grifola frondosa liquid fermentation strain has the advantages of low cost, short cycle, rapid growth, high purity and less pollution.

The invention discloses a process for preparing medicinal mushrooms and polyporus rhinocerus cooke extracts and their constituents, the extracts have very strong anti-propagation actions to cancer cells, thus the pharmaceutical compositions containing the extracts are effective in the prevention and treatment of cancers. The invention also provides a functional food containing effective dose of the said extracts as active components.

The invention discloses a method for improving the VD in the fruiting bodies of edible and medicinal fungi. 2 The method for content comprises the following steps: (1) making the fruit body of edible and medicinal fungus into a suspension; (2) controlling the irradiation temperature at 30°C-60°C, and ultraviolet rays at different single wavelengths, combined wavelengths or stepwise combined wavelengths Under light irradiation, stir the suspension for 0.5h-4h. The benefit of the present invention is that it significantly improves the VD in the fruiting bodies of edible and medicinal fungi 2 content, thereby improving the nutritional value and functional edible quality of edible and medicinal fungi, how to stabilize and improve the VD in edible and medicinal fungi 2 The scientific problem of content provides green, economical, convenient, and easy-to-promote theoretical support and solutions, and opens up new ideas for the accumulation and strengthening of functional nutrients in edible and medicinal fungi.

Processes for preparing lanostane triterpenes from the medicinal mushroom Ganoderma lucidum, and related compounds are described. Compounds, compositions, and methods for treating cancer are also described.

Disclosed are a method for culturing mushroom mycelia using grains, a culture product, and use of the culture product. Edible or medicinal mushroom mycelia are inoculated and cultured in solid media made of grains. Induction of the cultured mushroom mycelia to undergo autolysis produces autolysates rich in antitumorigenic and other medicinally useful materials. The squeezing of the autolysates produces a liquid filtrate, leaving a paste. The filtrate is concentrated for use in foods or medicines. The paste is processed into a nutrient-rich gruel or other foods.